The OncoDx Panel NGS (Next-Generation Sequencing) Genetic Test is a sophisticated diagnostic tool designed to provide comprehensive insights into the genetic mutations associated with various cancers. Offered at DNA Labs UAE, this cutting-edge test utilizes the latest in sequencing technology to analyze multiple genes simultaneously, helping in the identification of specific mutations that may influence cancer development, progression, and response to treatment.
With a focus on precision medicine, the OncoDx Panel aids oncologists in tailoring treatment plans to the individual genetic profile of a patient's tumor, potentially improving outcomes and minimizing unnecessary treatments. It covers a wide range of cancer types, offering valuable information for both solid tumors and hematological malignancies.
The test is priced at 4400 AED, reflecting the advanced technology and expertise required to conduct such a comprehensive genetic analysis. By choosing to undergo the OncoDx Panel NGS Genetic Test at DNA Labs UAE, patients and their healthcare providers are taking a significant step towards a more personalized approach to cancer care, leveraging genetic insights to make informed decisions about treatment strategies.
The Solid Tumor Panel NGS (Next-Generation Sequencing) Genetic Test is a sophisticated diagnostic tool available at DNA Labs UAE, designed to identify genetic mutations across a broad range of solid tumors. This comprehensive test, priced at 4400 AED, utilizes cutting-edge NGS technology to analyze multiple genes simultaneously, providing insights that can guide personalized treatment plans for cancer patients. By pinpointing specific genetic abnormalities within tumor DNA, the test aids in determining the most effective treatment strategies, potentially improving patient outcomes. DNA Labs UAE ensures precise and reliable results, making this test a valuable asset in the management and treatment of various solid tumor cancers.
The Autism Gene Panel Test is a comprehensive diagnostic tool offered by DNA Labs UAE, designed to detect genetic markers associated with autism spectrum disorders (ASD). This cutting-edge test analyzes multiple genes simultaneously, providing insights into the genetic predispositions that may contribute to the development of ASD. With a cost of 4400 AED, the test is a valuable resource for families seeking to understand the genetic factors that may influence autism in their loved ones. By identifying specific genetic variations, the Autism Gene Panel Test can aid in early diagnosis, inform treatment strategies, and offer families a deeper understanding of the condition. Conducted in the advanced facilities of DNA Labs UAE, this test is a step forward in personalized medicine, offering hope and clarity to those affected by autism spectrum disorders.
The Cystic Fibrosis CFTR Full Gene Sequence Analysis Test is a comprehensive diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the CFTR (Cystic Fibrosis Transmembrane Conductance Regulator) gene. This gene is crucial for the production of sweat, digestive fluids, and mucus. Mutations in the CFTR gene are the primary cause of cystic fibrosis (CF), a serious genetic disorder that affects the lungs, digestive system, and other organs.
By examining the entire gene sequence, this test can detect a wide array of mutations, providing valuable information for confirming a diagnosis of cystic fibrosis, understanding the specific genetic mutations present, and guiding treatment decisions. It is particularly useful for families with a history of CF, couples considering pregnancy, and individuals with symptoms suggestive of cystic fibrosis.
The cost of the Cystic Fibrosis CFTR Full Gene Sequence Analysis Test at DNA Labs UAE is 4400 AED. This investment covers the thorough analysis required to identify potential mutations in the CFTR gene, offering patients and their families crucial insights into the condition and aiding in the management of cystic fibrosis.
The Lung Cancer Panel 2 EGFR/ALK1/ROS1 Test offered by DNA Labs UAE is a comprehensive diagnostic tool designed to identify specific genetic mutations associated with lung cancer. Priced at 4500 AED, this test focuses on the detection of mutations in the EGFR, ALK1, and ROS1 genes, which are critical in the development and progression of lung cancer. By pinpointing these mutations, the test aids in determining the most effective treatment plan for patients, enabling personalized therapy approaches. This advanced molecular testing is crucial for patients with non-small cell lung cancer (NSCLC), as targeted therapies can significantly improve outcomes for those with identifiable mutations. Conducted in the state-of-the-art facilities of DNA Labs UAE, the test ensures high accuracy and reliability, providing essential insights for oncologists and patients navigating lung cancer treatment options.
The Maturity-Onset Diabetes of the Young (MODY) Gene Panel Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify genetic mutations associated with MODY, a form of diabetes that typically presents in adolescence or early adulthood. Priced at 4500 AED, this comprehensive test analyzes multiple genes known to be linked to MODY, providing crucial information for the accurate diagnosis and management of the condition. By pinpointing the specific genetic variant(s) responsible for MODY in an individual, healthcare professionals can tailor treatment strategies more effectively, potentially improving patient outcomes. This test is particularly valuable for individuals with a family history of diabetes or those showing symptoms of diabetes at an unusually young age, facilitating early intervention and personalized care plans.
The m-FISH (Multiplex Fluorescence In Situ Hybridization) test is a sophisticated and powerful cytogenetic technique used to detect and localize the presence or absence of specific DNA sequences on chromosomes. This method utilizes fluorescent probes that bind to specific chromosome regions, allowing for the simultaneous visualization of multiple genetic abnormalities in a single experiment. It's particularly useful in the field of cancer genetics, prenatal diagnostics, and for the study of chromosomal abnormalities in genetic disorders.
At DNA Labs UAE, the m-FISH test is offered for a cost of 4400 AED. This facility is known for its state-of-the-art genetic testing services, providing accurate and comprehensive results. The m-FISH test at DNA Labs UAE is performed by experienced professionals using the latest technology, ensuring high-quality diagnostics for patients. Whether for clinical or research purposes, the m-FISH test at DNA Labs UAE is a valuable tool for gaining insights into complex genetic conditions.
The Microarray 60K AFCVS (Array-based Comparative Genomic Hybridization for Virtual Karyotyping) alongside traditional Karyotyping tests represent advanced genetic testing methodologies offered by DNA Labs UAE. Priced at 4500 AED, this comprehensive testing package is designed to detect chromosomal abnormalities and genetic disorders with high precision.
Microarray 60K AFCVS is a sophisticated technique that examines the entire genome in a single assay, allowing for the detection of submicroscopic genetic changes that are beyond the resolution of conventional karyotyping. This test scans the genome for both large and small variations, including deletions, duplications, and copy number variations (CNVs), which can be linked to a wide range of genetic disorders.
In contrast, the Karyotyping test involves examining the chromosomes under a microscope to identify any structural abnormalities or changes in chromosome number, such as those seen in conditions like Down syndrome, Turner syndrome, or Klinefelter syndrome. When combined, these tests offer a comprehensive genetic analysis, enhancing the ability to diagnose and understand various genetic conditions.
Performed at DNA Labs UAE, a facility known for its state-of-the-art technology and expertise in genetic analysis, this dual testing approach ensures a thorough examination of the genetic makeup, providing valuable insights for diagnosis, treatment planning, and genetic counseling. The cost of 4500 AED reflects the extensive analysis and detailed information these tests deliver, making it a valuable investment for those seeking in-depth genetic understanding.
Microarray 60K Peripheral Blood/Cord Blood/Fetal Blood and Karyotyping Test is a comprehensive genetic screening procedure offered by DNA Labs UAE. This advanced test is designed to analyze over 60,000 genetic markers across peripheral blood, cord blood, and fetal blood samples, providing an extensive overview of chromosomal abnormalities and genetic variations. The microarray technique enables high-resolution detection of genomic imbalances, including deletions, duplications, and other significant alterations that may be linked to various genetic disorders and conditions.
In addition to the microarray analysis, this test incorporates karyotyping, a method that visually examines the chromosomes in a cell to identify any structural abnormalities or changes in chromosome number. This dual approach enhances the diagnostic capabilities, offering a more detailed genetic profile that can be crucial for early detection, diagnosis, and management of genetic diseases.
Performed at the state-of-the-art facilities of DNA Labs UAE, the test is priced at 4500 AED. It is a valuable diagnostic tool for expecting parents, individuals with a family history of genetic disorders, or anyone seeking a comprehensive genetic assessment. The results from this test can provide critical insights for personalized medical care, guiding decisions on treatment, management, and preventive measures for a range of genetic conditions.
The "Liquid Biopsy Cancer Therapy Chemo Sensitivity Test" offered by DNA Labs UAE is a groundbreaking diagnostic procedure designed to enhance the personalization and effectiveness of cancer treatment. Priced at 4500 AED, this test utilizes a non-invasive method by analyzing a sample of the patient's blood to detect and monitor cancer cells or DNA from tumors circulating in the bloodstream. This innovative approach allows oncologists to identify the specific characteristics of the cancer, including its genetic makeup, which can significantly influence the choice of chemotherapy drugs or other treatments.
By assessing the sensitivity of cancer cells to different chemotherapy agents, the test aims to guide doctors in selecting the most effective treatment regimen for each individual patient, potentially increasing the chances of successful outcomes while minimizing unnecessary side effects. The liquid biopsy technique represents a significant advancement in the field of oncology, offering a more dynamic and less invasive alternative to traditional biopsy methods. Conducted at the state-of-the-art facilities of DNA Labs UAE, this test stands as a testament to the evolving landscape of cancer treatment, where precision medicine is becoming increasingly central to patient care strategies.
